We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
19 hedge funds and large institutions have $26M invested in ADMA Biologics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14.57% more ownership
Funds ownership: 34.58% → 49.15% (+15%)
0% more funds holding
Funds holding: 19 → 19 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
22% less capital invested
Capital invested by funds: $33.2M → $26M (-$7.16M)
Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IHM
Iguana Healthcare Management
New York
|
+$1.38M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$538K |
| 3 |
Millennium Management
New York
|
+$63.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$35.1K |
| 5 |
Renaissance Technologies
New York
|
+$30K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$2.52M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$1.34M |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$74K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$49.3K |
| 5 |
SIM
Spark Investment Management
New York
|
-$39K |
